Description
| What It Is | KLOW is a multi-peptide research formulation combining BPC-157, TB-500 (Thymosin Beta-4 sequence), KPV, and GHK-Cu. The blend is supplied for experimental investigation of coordinated peptide signaling pathways in controlled laboratory systems. |
| What It’s Derived From | KLOW incorporates four independently characterized peptide sequences: BPC-157 – derived from a partial sequence of a gastric protein known as body protection compound (BPC).TB-500 – corresponds to the 43–amino–acid sequence motif of thymosin beta-4, an actin-binding peptide identified in eukaryotic cells.KPV (Lys-Pro-Val) – derived from the C-terminal region of alpha-melanocyte–stimulating hormone (α-MSH).GHK-Cu – formed from the naturally occurring tripeptide Gly-His-Lys complexed with copper(II), identified in human plasma and other biological fluids. |
| What Research Focuses On | Experimental models evaluate this peptide combination in studies examining nitric oxide–associated signaling, actin-cytoskeletal dynamics, NF-κB–related transcriptional pathways, extracellular matrix–associated molecular markers, and peptide–metal interaction mechanisms under defined preclinical conditions. |
Reviews
There are no reviews yet.